Normal mice are fed with diet enriched in fat and diabetes is induced by streptozotocin administration. This model develops clinically relevant features of NASH where diabetes exacerbates the NASH phenotype.
At Triangulum Biopharma, having directly worked on drug discovery and development, we understand the dynamics of the process. We understand what is needed, how fast it is needed, and how to help design the studies to obtain rapid and clear answers to our clients.